2 months to 16 years:
Cl: 3,3 ml/min/kg
Vd: 0,3 l/kg
T1/2: 1,7 hour
[SmPC Cefepim]
No information is present at this moment.
No information is present at this moment.
| Very serious bacterial infections including febrile neutropenia |
|---|
Children 2 months up to 40 kg
| Creatinine clearance (ml/min.) |
Serious infections | Very serious infections, febrile neutropenia |
| > 50 | No dose adjustment required | No dose adjustment required |
| 30 -50 | Normal single dose (50 mg/kg/dose), dosing interval 24 hours | Normal single dose (50 mg/kg/dose), dosing interval 12 hours |
| 11-29 | Half of normal single dose halveren (25 mg/kg/dose), dosing interval 24 hours | Normal single dose (50 mg/kg/dose), dosing interval 24 hours |
| ≤ 10 | Quarter of normal single dose (12,5 mg/kg/dose), dosing interval 24 hours | Half of normal single dose (25 mg/kg/dose), dosing interval 24 hours |
Infants 1-2 months
| Creatinine clearance (ml/min.) |
Serious infections | Very serious infections, febrile neutropenia |
| > 50 | No dose adjustment required | No dose adjustment required |
| 30 -50 | Normal single dose (30 mg/kg/dose), dosing interval 24 hours | Normal single dose (30 mg/kg/dose), dosing interval 12 hours |
| 11-29 | Half of normal single dose halveren (15 mg/kg/dose), dosing interval 24 hours | Normal single dose (30 mg/kg/dose), dosing interval 24 hours |
| ≤ 10 | Quarter of normal single dose (7,5 mg/kg/dose), dosing interval 24 hours | Half of normal single dose (15 mg/kg/dose), dosing interval 24 hours |
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
The safety profile of cefepim in infants and children is similar to that in adults with that in adults.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific warnings and precautions in children.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| First-generation cephalosporins | ||
|---|---|---|
| J01DB05 | ||
| J01DB04 | ||
| J01DB01 | ||
| J01DB03 | ||
| Second-generation cephalosporins | ||
|---|---|---|
| J01DC04 | ||
| J01DC03 | ||
| J01DC02 | ||
| Third-generation cephalosporins | ||
|---|---|---|
| J01DD08 | ||
| J01DD01 | ||
| J01DD13 | ||
| J01DD52 | ||
| J01DD02 | ||
| J01DD14 | ||
| J01DD04 | ||
| Monobactams | ||
|---|---|---|
| J01DF01 | ||
| Carbapenems | ||
|---|---|---|
| J01DH03 | ||
| J01DH51 | ||
| J01DH02 | ||
| MONOBACTAMS | ||
|---|---|---|
| J01DF01 | ||
| Other cephalosporins and penems | ||
|---|---|---|
| J01DI02 | ||